Emergent BioSolutions Inc. (EBS)
NYQ – Real Time Price. Currency in USD
4.48
+0.03 (0.67%)
Market open: Aug 12, 2026, 11:22 AM EDT
4.46
+0.01 (0.22%)
Previous after-hours: Aug 11, 2026, 7:57 PM EDT
Find any stock by ticker or company name

NYQ – Real Time Price. Currency in USD
4.48
+0.03 (0.67%)
Market open: Aug 12, 2026, 11:22 AM EDT
4.46
+0.01 (0.22%)
Previous after-hours: Aug 11, 2026, 7:57 PM EDT
No Data
There are no news for this stock.
Total debt $588.2M significantly exceeds cash reserves ($140.9M), raising financial stability concerns
Total current assets $666.0M exceed Total current liabilities $122.8M, highlighting excellent liquidity
Debt-to-equity ratio (1.7) far exceeds the industry average, reflecting over-leverage
Interest coverage ratio (7x) indicates the company easily manages its debt payments
The company generates positive free cash flow $54.0M, supporting its financial health
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 5.42 | 2.52 | 10 | |
| Quick ratio | 2.95 | 1.78 | 10 | |
| Debt to Equity | 1.72 | -0.80 | 4.0 | |
| Debt to Assets | 0.53 | 0.73 | 4.0 | |
| Interest coverage | 6.62 | -13.90 | 10 | |
| Weighted average score | 7.6 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 1.12B | 1.05B | 1.04B | 743M | 770M |
| Gross Profit | 367M | 293M | 305M | 351M | 363M |
| Operating Income | -159M | -172M | -58M | 110M | 137M |
| Net Income | -212M | -761M | -191M | 53M | -177M |
| EBITDA | -10M | -43M | 54M | 209M | 233M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | -29.47 | -123.11 | 1.0 |
| Next quarter | 13.95 | 84.88 | 9.0 |
| Current year | -6.71 | -98.04 | 1.0 |
| Next year | 28.71 | 2933.33 | 10 |
| Weighted average score | 5.3 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 50.1 | -2749.99 | 185.71 | 249.17 | 7.8 |
| Y/Y | 66.29 | -1401.66 | 275 | -47.82 | 5.5 |
| 3y average | -11.8 | -18.94 | 227.39 | 162.12 | 5.5 |
| 5y average | -11.66 | -56.25 | 104.31 | -19.76 | 3.3 |
| Weighted average score | 5.5 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |